By Rishika Sadam

NEW DELHI (Reuters) -India’s drug regulator plans to ease processes, set fixed approval timelines and explore artificial intelligence to improve execution, its chief said on Thursday.

“We’re trying to increase our efficiency, cutting down on regulations so that we create more and more resources within our system,” the Central Drugs Standard Control Organisation’s Rajeev Raghuvanshi said in an interview at the sidelines of an industry event.

“The way for the future is to make the regulation lighter and execution is stronger,” the Drugs Controller General added, without giving details of the regulator’s plans.

On artificial intelligence, Raghuvanshi said the regulator was examining how to avoid legal infringements.

The agency said on Wednesday it has halved the processi

See Full Page